GlaxoSmithKline GmbH & Co. KG
Biotechnology
-
Short facts
-
- Manufacturer
- Research & Development
- Year founded 2001
- 380 Employees (site)
- Turnover: >=125m EUR
Products/services: We prevent and treat disease with vaccines, specialty and general medicines.
Basic data
Company
GlaxoSmithKline GmbH & Co. KG
Street
Prinzregentenplatz 9
PC / City
81675 München
County
Upper Bavaria
Phone
+49 89 36044-0
Fax
+49 89 36044.8000
Homepage
Language skills
English, German
Contact person
Sales / marketing: Claudia Kubacki (Mrs.)
Management: Victoria Williams (Mrs.)
Profile/competences
Core competencies
GSK is a global biopharma company with the purpose to unite science, technology and talent to get ahead of disease together.
We aim to positively impact the health of 2.5 billion people over the next 10 years. Our bold ambitions for patients are reflected in new commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.
We prevent and treat disease with vaccines, specialty and general medicines.
At the heart of this is our R&D focus on the science of the immune system, human genetics and advanced technologies. We will focus on four therapeutic areas: infectious diseases, HIV, oncology, and immunology.
Key sectors / sub-sectors
- Biotechnology: Prophylactic drug development
- Biotechnology: Therapeutic drug development
NACE industries
- Manufacture of basic pharmaceutical products and pharmaceutical preparations 21
- Scientific research and development 72
Certifications
not available
Sales markets - target industries
not available
Sales markets - target countries
not available
Cooperation offers
not available